Resmed (RSMDF) Other financing activities (2009 - 2021)

Resmed has reported Other financing activities for 13 years, with the latest figure at $16.1 million in Q4 2021.

• For the quarter ending Q4 2021, Other financing activities rose 4.76% year-over-year to $16.1 million; the trailing twelve-month figure through Dec 2021 stood at $48.7 million (down 67.02% YoY), and the FY2021 full-year result was -$50.2 million, down 187.93% from the prior year.
• Other financing activities for Q4 2021 stood at $16.1 million, down from $17.3 million in the prior quarter.
• The five-year high for Other financing activities was $102.2 million in Q2 2020, with the low at -$914000.0 in Q2 2018.
• Historically, Other financing activities has averaged $16.5 million across 5 years, with a median of $13.0 million in 2019.
• Annual changes were most pronounced in 2020 — Other financing activities surged 45727.68% — and 2021, when it tumbled 100.27%.
• Resmed's Other financing activities stood at $12.0 million in 2017, then advanced by 4.53% to $12.5 million in 2018, then advanced by 12.09% to $14.1 million in 2019, then climbed by 9.34% to $15.4 million in 2020, then rose by 4.76% to $16.1 million in 2021.
• The last three Other financing activities figures came in at $16.1 million (Q4 2021), $17.3 million (Q3 2021), and -$271000.0 (Q2 2021), per Business Quant data.